Drug factory · FDA FEI 3003974261
Flamma SpA
Via Cascina Secchi 217, Isso, Italy
Problems found, fixed voluntarily at FDA's last inspection, Apr 15, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2022: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Rilzabrutinib | Makes the active ingredient | Genzyme Corporation | 58468-0251 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 15, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.